Primecap Management

Primecap Management’s Mereo BioPharma MREO Stock Holding History

Primecap Management’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-54,000	Closed	-$222K	–	336
2024 Q3	$222K	Hold	54,000	–	–	﹤0.01%	335
2024 Q2	$194K	Hold	54,000	–	–	﹤0.01%	331
2024 Q1	$178K	Hold	54,000	–	–	﹤0.01%	333
2023 Q4	$125K	Sell	54,000 -25,000	-32%	-$47.8K	﹤0.01%	334
2023 Q3	$102K	Sell	79,000 -78,700	-50%	-$104K	﹤0.01%	331
2023 Q2	$208K	Sell	157,700 -138,830	-47%	-$161K	﹤0.01%	326
2023 Q1	$210K	Sell	296,530 -700	-0.2%	-$630	﹤0.01%	329
2022 Q4	$223K	Sell	297,230 -17,530	-6%	-$14.4K	﹤0.01%	330
2022 Q3	$271K	Sell	314,760 -6,900	-2%	-$8.44K	﹤0.01%	332
2022 Q2	$360K	Sell	321,660 -9,240	-3%	-$7.16K	﹤0.01%	336
2022 Q1	$371K	Sell	330,900 -1,300	-0.4%	-$1.68K	﹤0.01%	336
2021 Q4	$532K	Sell	332,200 -7,400	-2%	-$14.8K	﹤0.01%	337
2021 Q3	$822K	Sell	339,600 -149,338	-31%	-$395K	﹤0.01%	333
2021 Q2	$1.55M	Sell	488,938 -162	-0%	-$544	﹤0.01%	318
2021 Q1	$1.65M	Hold	489,100	–	–	﹤0.01%	313
2020 Q4	$1.75M	Hold	489,100	–	–	﹤0.01%	304
2020 Q3	$1.28M	Hold	489,100	–	–	﹤0.01%	297
2020 Q2	$1.5M	Sell	489,100 -54,275	-10%	-$95.8K	﹤0.01%	283
2020 Q1	$560K	Sell	543,375 -58,387	-10%	-$101K	﹤0.01%	283
2019 Q4	$1.97M	Sell	601,762 -81,594	-12%	-$208K	﹤0.01%	274
2019 Q3	$1.98M	Sell	683,356 -12,754	-2%	-$38.6K	﹤0.01%	274
2019 Q2	$1.67M	Buy	+696,110	New	+$3.04M	﹤0.01%	281

Other funds holding MREO

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Alkeon Capital Management

Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return